Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmune bullous disorders.

Rüdiger Eming1, Michael Hertl,

  • 1Klinik für Dermatologie und Allergologie, Philipps-Universität Marburg, Marburg, Germany. eming@med.uni-marburg.de

Clinical Chemistry and Laboratory Medicine
|February 16, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinctive Reactivity to the C-terminal Epitope of BP180 Characterizes Immune Checkpoint Inhibitor-associated Bullous Pemphigoid, and an ELISA Based on the BP180 Ectodomain Enables Prompt Diagnosis in a Subset of Patients.

Acta dermato-venereologica·2026
Same author

A case series of immune checkpoint inhibitor-induced bullous pemphigoid successfully treated with dupilumab and evidence for the BP180 midportion epitope as a preferential autoantigenic target.

Frontiers in medicine·2026
Same author

International development of Investigator Global Assessment scores for pemphigus.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Wnt-associated DKK3 in keratinocytes mediates radiation-induced hyperplasia, dermatitis and skin fibrosis.

Signal transduction and targeted therapy·2026
Same author

Digital health applications, telemedicine and large language models in dermatology: results of a Germany-wide survey.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Same author

Structured Symptom Assessment in Dermato-Oncology Patients-A Prospective Observational Study of the Usability of a Symptom Questionnaire.

Cancers·2025
Same journal

Emerging blood-based diagnostic strategies for tuberculosis.

Clinical chemistry and laboratory medicine·2026
Same journal

Homocitrulline and 3-year mortality in older hospitalised adults: an exploratory study.

Clinical chemistry and laboratory medicine·2026
Same journal

Impact of age partitioning on classification discordance in pediatric ferritin reference intervals.

Clinical chemistry and laboratory medicine·2026
Same journal

National implementation of LOINC: translation methodology and experience from the Polish laboratory terminology standardization project.

Clinical chemistry and laboratory medicine·2026
Same journal

Harmonization of measurement units: mission impossible or ethical imperative?

Clinical chemistry and laboratory medicine·2026
Same journal

Analysis of albumin-to-creatinine ratio on automated analysers using a microsampling card (Capitainer DIP70 card) for the collection of urine.

Clinical chemistry and laboratory medicine·2026
See all related articles

Autoimmune bullous skin diseases involve autoantibodies attacking skin adhesion molecules, causing blisters. Immunofluorescence and serological tests are key for diagnosis and patient monitoring.

Area of Science:

  • Dermatology
  • Immunology
  • Autoimmune Diseases

Background:

  • Bullous skin diseases are organ-specific autoimmune disorders.
  • Autoantibodies target epidermal adhesion molecules or the basement membrane zone.
  • This binding leads to loss of cell adhesion, causing blisters and erosions.

Purpose of the Study:

  • To outline the diagnostic approaches for autoimmune bullous disorders.
  • To emphasize the role of immunofluorescence and serological testing.
  • To highlight methods for patient monitoring.

Main Methods:

  • Histopathology to determine blister location and disease subtype.
  • Direct immunofluorescence of perilesional skin to detect tissue-bound autoantibodies.
  • Indirect immunofluorescence using substrates like monkey esophagus and NaCl-split human skin to visualize circulating autoantibodies.

Related Experiment Videos

  • ELISA or immunoblot analysis using recombinant autoantigens for screening and follow-up.

    • Main Results:

    • Autoantibodies binding to specific targets cause characteristic blistering.
    • Immunofluorescence techniques are essential for accurate diagnosis.
    • Serological assays enable confirmation and monitoring of disease activity.

    Conclusions:

    • Autoimmune bullous disorders are diagnosed through a combination of clinical presentation, histopathology, and immunoserological methods.
    • Immunofluorescence and autoantibody screening are crucial for both initial diagnosis and long-term patient management.
    • Availability of recombinant autoantigens facilitates precise diagnosis and monitoring.